Oberle Mark 4
4 · Celanese CORP · Filed Feb 21, 2012
Insider Transaction Report
Form 4
Oberle Mark
SVP, Corporate Affairs
Transactions
- Sale
Series A Common Stock
2012-02-17$52.11/sh−11,400$594,054→ 24,872 total - Exercise/Conversion
Series A Common Stock
2012-02-17$15.16/sh+11,400$172,824→ 36,272 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-02-17−4,800→ 0 totalExercise: $15.16Exp: 2015-04-18→ Series A Common Stock (4,800 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-02-17−6,600→ 0 totalExercise: $15.16Exp: 2015-04-18→ Series A Common Stock (6,600 underlying)
Holdings
- 638.66(indirect: By 401(k))
Series A Common Stock
Footnotes (4)
- [F1]The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $51.87 to $52.50. The reporting person will provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range.
- [F2]Represents equivalent shares of Series A Common Stock held by the reporting person under the Celanese Americas Retirement Savings Plan as of January 31, 2012.
- [F3]Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vested with respect to 20% of the options on each of December 31, 2005, December 31, 2006, December 31, 2007, December 31, 2008 and March 31, 2009.
- [F4]Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vested with respect to 15% of the options on December 31, 2005, with repsect to 30% on each of December 31, 2006 and December 31, 2007, and with respect to 25% on December 31, 2008.